본문 바로가기

Variations in the Number of CCL3L1 Gene Copies and Kawasaki Disease in Korean Children

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q3Scopus Q2
저널
PEDIATRIC CARDIOLOGY33(8) · pp.1259 · 2012
피인용
Web of Science 5
JCR IF
JCR 2011 1.298
ISSN
0172-0643

저자

  1. Kim, Hye-Eun제1저자Asan Institute for Life Sciences, University of Ulsan, College of Medicine, South Korea
  2. Kim, Jae-JungAsan Institute for Life Sciences, University of Ulsan, College of Medicine, South Korea
  3. Han, Myung KiDepartment of Pediatrics, University of Ulsan, Gangneung Asan Hospital, South Korea
  4. Lee, Kyung-YilDepartment of Pediatrics, Catholic University of Korea, Daejeon St. Mary's Hospital, South Korea
  5. Song, Min SeobDepartment of Pediatrics, Inje University Paik Hospital, South Korea
  6. 이형두Department of Pediatrics, Pusan National University Hospital, South Korea
  7. Kim, Dong SooDepartment of Pediatrics, Yonsei University College of Medicine, Severance Children's Hospital, South Korea
  8. Yu, Jeong JinDepartment of Pediatrics, University of Ulsan College of Medicine, Asan Medical Center, South Korea
  9. Park, In-SookDepartment of Pediatrics, University of Ulsan College of Medicine, Asan Medical Center, South Korea
  10. Yun, Sin WeonDepartment of Pediatrics, Chung-Ang University Hospital, South Korea
  11. Hong, Young MiDepartment of Pediatrics, Ewha Womans University Hospital, South Korea
  12. Jang, Gi YoungDepartment of Pediatrics, Korea University Hospital, South Korea
  13. Lee, Jong-Keuk교신저자Asan Institute for Life Sciences, University of Ulsan, College of Medicine, South Korea

초록

High-dose intravenous immunoglobulin (IVIG) therapy is the highly effective and standard treatment for Kawasaki disease (KD). However, similar to 20 % of KD patients have persistent fever or recurrence of fever after the initial IVIG treatment, which increases the risk for coronary artery lesions (CALs). Furthermore, the mechanism of IVIG resistance in KD patients still is unknown. The number of CC chemokine ligand 3-like 1 (CCL3L1) gene copies is reported to be associated with KD and IVIG resistance in Japanese patients. In addition, the authors observed significant upregulation of the CCL3L1 gene expression after in vitro immunoglobulin treatment in B cell lines derived from KD patients. Therefore, this study of 459 KD patients and 496 healthy control subjects tested whether the number of CCL3L1 gene copies is associated with a risk of KD, CALs, and/or IVIG resistance in Korean KD patients. However, the number of CCL3L1 gene copies was not associated with KD (P = 0.18), CAL formation (P = 0.062), or the IVIG resistance (P = 0.90). Therefore, the results indicate that the number of CCL3L1 gene copies does not have a role in susceptibility to KD or CALs nor with IVIG resistance in Korean KD patients.

키워드

Copy number variation (CNV)ChemokineCC chemokine ligand 3-like 1 (CCL3L1)Kawasaki disease (KD)CONTAINING SEGMENTAL DUPLICATIONSAMERICAN-HEART-ASSOCIATIONLONG-TERM MANAGEMENTCARDIOVASCULAR-DISEASERHEUMATIC-FEVERSUSCEPTIBILITYPOLYMORPHISMSENDOCARDITISCOMMITTEECOUNCIL

식별자

WoS UID
000311792000003